Contact the Editorial Desk

Editorial correspondence

Pure Core Peptides welcomes notes on the research record itself: a citation quoted inaccurately, a newly published trial, an updated regulatory status, or a peer-reviewed study on Ipamorelin, NAD+, Semaglutide, or Tesamorelin that belongs on the references page. This kind of correction is read closely and taken seriously, because keeping the citations accurate is the whole point of this guide.

The most useful messages point to the specific page, the exact passage in question, and a supporting source — a DOI or PubMed link wherever possible — so the change can be checked against its source before anything is updated.

Editorial mailbox: editors@purecorepeptides.com

What this desk cannot do

So no message goes unanswered for the wrong reason, a few things fall outside what this guide can help with. It cannot recommend, advise on, or comment on personal use of any compound covered here; suggest a dose, schedule, or route of use for any individual; judge whether a cited trial's findings apply to someone's specific situation; or help locate, source, or evaluate a supplier of any compound. Semaglutide and Tesamorelin are prescription medicines available only through a licensed provider; anyone with a medical question should bring it to a licensed clinician rather than to this mailbox. Responses are not guaranteed and may take time, as the mailbox is checked periodically rather than continuously.